Assessment of HIV Serostatus Discloser and its Influence on Adherence to ARV Treatment among HIV-infected Adolescents in Addis Ababa, Ethiopia

Fikadu, Fikrte (2014) Assessment of HIV Serostatus Discloser and its Influence on Adherence to ARV Treatment among HIV-infected Adolescents in Addis Ababa, Ethiopia. Masters thesis, Addis Ababa University.

[img] PDF (Assessment of HIV Serostatus Discloser and its Influence on Adherence to ARV Treatment among HIV-infected Adolescents in Addis Ababa, Ethiopia)
Final Research FIKRTE FIKADU.pdf - Accepted Version
Restricted to Repository staff only

Download (1MB) | Request a copy

Abstract

Back ground: Along with the increased survival of children infected with HIV, disclosure of HIV status to children remains a complex and a critical clinical issue in the care of HIV-infected children. Disclosed HIV status has been identified as one of the factors associated with better adherence and also essential for the secondary prevention of HIV transmission. However, HIV status disclosure of adolescent represents a challenge for the family and for medical staff. Objective: To assess the magnitude of HIV serostatus disclosure and its effect on ART treatment adherence among HIV-infected adolescents in ART care and treatment providing health facilities in Addis Ababa. Methods: A facility based cross-sectional study design was conducted among 403 adolescents receiving ART in the selected six health facilities of Addis Ababa. Caregivers of adolescents of aged 10-18 years, were interviewed using a structured questionnaire. Three days intensive training was given for all supervisors and data collectors. Stepwise logistic regression was conducted to identify the association of disclosure to HIV status and with adherence to ARV medication, Data entry and analyses was carried out using EPI info and SPSS version 16 statistical packages respectively. X RESULT: Three hundred and ninety six parents of adolescents on ART participated in this study making the response rate at 98%. Median age of the adolescents was 14 years. The level of HIV states discloser was 47%. Data showed that age greater than 14 years [AOR=(95% CI) 5.20 = (2.46-12.29)] and lower educational states of the care givers[AOR=(95% CI) 5.20 = (2.46-12.29)] were significant predictors for being disclosed. Similarly being disclosed to their HIV status and being in a fixed dose HAART regimen [AOR=(95% CI)9.94,(4.48-22.08)] and [AOR and (95% CI) 8.40= (2.48-28.47)] respectively were significantly associated with good HAART adherence. CONCLUTION: More than half (53%) of the adolescents who participated in the study did not know their HIV serostatus however, disclosed HIV status was significantly associated with good HAART adherence. The disclosure process should be thus systematically encouraged and organized among adolescent populations in order to improve their ARV medication adherence and prevent further HIV transmission.

Item Type: Thesis (Masters)
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RA Public aspects of medicine > RA1001 Forensic Medicine. Medical jurisprudence. Legal medicine
Divisions: Africana
Depositing User: Vincent Mpoza
Date Deposited: 01 Nov 2018 09:58
Last Modified: 01 Nov 2018 09:58
URI: http://thesisbank.jhia.ac.ke/id/eprint/7258

Actions (login required)

View Item View Item